S. Frank Friedman's Insider Trades & SAST Disclosures

S. Frank Friedman's most recent trade in Deciphera Pharmaceuticals Inc was a trade of 4,727 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 16, 2024.

Share

Note

This is a custom search result for pattern S. Frank Friedman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Deciphera Pharmaceuticals Inc	S. Frank Friedman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2024	4,727	4,727	-		-	Stock Option (Right to Buy)
Deciphera Pharmaceuticals Inc	Frank S. Friedman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jun 2023	30,000	30,000	-		-	Stock Option (Right to Buy)
Deciphera Pharmaceuticals Inc	Frank S. Friedman	Director	Purchase of securities on an exchange or from another person at price $ 13.88 per share.	08 Jun 2023	10,000	10,000 (0%)	0%	13.9	138,828	Common Stock
Deciphera Pharmaceuticals Inc	Frank S. Friedman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2023	3,269	3,269	-		-	Stock Option (Right to Buy)
Deciphera Pharmaceuticals Inc	Frank S. Friedman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2022	18,500	18,500	-		-	Stock Option (Right to Buy)
Deciphera Pharmaceuticals Inc	Frank S. Friedman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jan 2022	9,570	9,570	-		-	Stock Option (Right to Buy)
Deciphera Pharmaceuticals Inc	Frank S. Friedman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2021	12,000	12,000	-		-	Stock Option (Right to Buy)
Deciphera Pharmaceuticals Inc	Frank S. Friedman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jan 2021	1,563	1,563	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades